The UAB Department of Physical Therapy is in Phase 3 of a Clinical Trial that studies exercise in Parkinson called SPARX3. They are seeking volunteers to participate to determine how the effects of aerobic exercise on people with Parkinson’s could benefit the delay in disease progression.
SPARX3 is a research study to learn more about the effects of aerobic exercise on people with Parkinson’s disease who have not yet started medication for their PD. It will compare the effects of moderate intensity treadmill exercise to high intensity treadmill exercise on the signs and symptoms of Parkinson’s disease.
Participants will receive information regarding their health status at no cost. This may include:
You may be eligible to participate if you:
Have been diagnosed with Parkinson’s disease within the last 3 years and are not taking medication for your PD symptoms
You do not plan to start medication for PD within the next 6 months
Are willing to take part in a regular treadmill exercise program four times per week for 18 months and participate in study visits periodically for 24 months
You are 40-80 years old
You are not already participating in a structured exercise program
This study is funded by the National Institute of Neurological Disorders and Stroke. The principle investigator for this study is Christopher Hurt, Ph.D. Participants are being recruited under study number IRB-300007184.
To participate, call or email Sarah Bruton at 1.205.975.1008, firstname.lastname@example.org